By analyzing both the human CRC samples that we collected and publicly accessed data, we inferred that RIG-I expression in tumor-infiltrating CD8+ T cells was positively associated with poor prognosis of patients with advanced CRC. The gene discussed is CD8A; the disease is neoplasm.